Blood Cancer Immunotherapy Cell therapies transforming treatment More than 175,000 new cases of leukemia, lymphoma, and multiple myeloma are expected this year in the United States. Fortunately, a revolution in blood cancer treatment has arrived with immune checkpoint blockade and CAR T cell therapies providing new options for patients. Several immunotherapies are already FDA-approved, and ongoing research demonstrates even greater potential for new treatments, especially in adoptive cell therapy. Join Dr. Marcel van den Brink of Memorial Sloan Kettering Cancer Center in a Q&A discussion about different immunotherapies used in the treatment of blood cancers and new treatments in development to bring the benefits of immunotherapy to even more patients. Breast Cancer Immunotherapy Colorectal Cancer Immunotherapy Kidney Cancer Immunotherapy Lung Cancer Immunotherapy Pancreatic Cancer Immunotherapy Prostate Cancer Immunotherapy Intro to CRI Cancer Immunotherapy Basics: Harnessing Our Immune System to Fight Cancer Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments Patient Perspectives: Immunotherapy and Clinical Trial Experiences Bladder Cancer Immunotherapy Gynecologic Cancer Immunotherapy Liver Cancer Immunotherapy Skin Cancer and Melanoma Immunotherapy Understanding and Overcoming Barriers to Accessing Cancer Care Go back to event page Go back Hosts Tamron Hall Award-Winning TV Host, Journalist, Executive Producer, and Philanthropist CRI Experts Julie Brahmer, MD Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Andrea Cercek, MD Memorial Sloan Kettering Cancer Center Luis Diaz Jr., MD Memorial Sloan Kettering Cancer Center Peter E. Fecci, MD, PhD Duke Cancer Center, DukeHealth, and Duke University Lawrence Fong, MD UCSF Helen Diller Family Comprehensive Cancer Center Matthew D. Galsky, MD The Tisch Cancer Institute Sangeeta Goswami, MD, PhD The University of Texas MD Anderson Cancer Center Elizabeth Ann Mittendorf, MD, PhD Dana-Farber/Harvard Cancer Center Kunle Odunsi, MD, PhD University of Chicago Medicine Comprehensive Cancer Center Joseph E. Ravenell, MD Perlmutter Cancer Center NYU Langone Health Marcel van den Brink, MD, PhD Memorial Sloan Kettering Cancer Center Ana I. Velázquez Mañana, MD MSc UCSF Helen Diller Family Comprehensive Cancer Center Robert H. Vonderheide, MD, DPhil University of Pennsylvania Health System Jennifer Wargo, MD, MMSc The University of Texas MD Anderson Cancer Center Jeffrey S. Weber, MD, PhD Perlmutter Cancer Center NYU Langone Health Theodore H. Welling, MD Perlmutter Cancer Center NYU Langone Health CRI ImmunoAdvocates LaToya Bolds-Johnson, PA-C, CAQ-EM Breast Cancer Advocate & Thriver Stephen Estrada Long-term Survivor of Stage 4 Colorectal Cancer Stephanie Gangi Breast Cancer Navigator Sunshine Pegues Lung Cancer Veteran John White Prostate Cancer Veteran CRI Moderators Brian Brewer Cancer Research Institute Sponsors Gold Silver Contributor Friend Host Institutions Request a clinical trials orientation appointment Request Questions? Contact[email protected]
